![]() |
市场调查报告书
商品编码
1820305
2025 年至 2033 年血液净化设备市场规模、份额、趋势及预测(依产品类型、适应症、最终用户及地区)Blood Purification Equipment Market Size, Share, Trends and Forecast by Product Type, Indication, End User, and Region, 2025-2033 |
2024年,全球血液净化设备市场规模达222亿美元。展望未来, IMARC Group预测,到2033年,该市场规模将达到367亿美元,2025-2033年期间的复合年增长率为5.76%。目前,亚太地区占据市场主导地位。肾臟相关疾病发病率的上升、重症监护服务需求的不断增长以及医疗技术的持续创新,都极大地促进了该行业的扩张。这些因素共同推动了血液净化设备市场的成长,并对全球血液净化设备市场份额产生了积极影响。
血液净化设备市场正稳步向紧凑便携型设备转变。这主要是因为人们越来越重视居家治疗,以及慢性病患者对灵活照护方案的需求。可携式装置易于使用、设定快捷,并能提高使用者的舒适度,这对老年患者或需要定期透析的患者尤其有益。这些设备正变得越来越先进,其功能可在不影响性能的情况下实现高效过滤。医疗保健提供者也支持这种转变,因为便携式设备可以减少医院和诊所的患者负担。 2024 年的一个显着发展是推出具有即时监控功能的轻量级型号,从而提高居家使用的安全性。製造商也在专注于延长电池寿命和打造用户友好的介面。透过联网应用程式提供的远端支持,可以帮助用户在最少的监督下管理治疗。
美国是市场变革的关键力量,其驱动力在于血液净化系统尖端技术的快速应用以及对以患者为中心的医疗服务的高度重视。美国的医疗服务提供者优先考虑效率、准确性和缩短治疗时间,这促使製造商投资于具有即时监控和自动化控制功能的更智慧的设备。人工智慧诊断、改进的膜技术和用户友好介面的整合在医院和门诊透析中心变得越来越普遍。 2024年,多家美国公司推出了人工智慧辅助设备,可根据患者生命征象自动调整净化週期,进而提高治疗的精准度和安全性。此外,连接性也发生了显着转变,基于云端的资料追踪现已用于远端管理患者记录和装置效能。这些创新有助于临床医生更快地做出决策,同时也支持远距病患管理—随着远距医疗在全国的扩展,远距病患管理已成为一项重要功能。
肾臟疾病盛行率不断上升
血液净化设备需求激增的主要原因是慢性肾臟病 (CKD) 和末期肾病 (ESRD) 盛行率的不断上升。 NCBI 报告称,过去三十年,全球 CKD 的发病率和盛行率上升了约 40%。由于肾臟功能受损,无法有效排除毒素,现在越来越多的患者依赖透析和类似的血液净化方法。 CKD 病例的增加、全球健康趋势、血液透析和血液滤过系统的普及以及更容易患肾臟相关疾病的老年人口的增长等因素正在推动市场扩张。为此,製造商不断提高设备的安全性、舒适度和患者护理的效率。已开发国家和发展中国家的医疗保健基础设施都在扩大透析基础设施,从而将这种血液净化技术推广到更广泛的人群,这为血液净化设备市场带来了积极的前景。
血液净化技术的进步
推动血液净化设备市场成长的另一个主要因素是血液净化技术的更先进发展。过滤和吸附技术的进步显着改善了血液中毒素、免疫复合物和代谢废物的清除。高通量透析器和新一代血液灌流器等现代系统为败血症、自体免疫疾病和多重器官功能障碍患者提供了更佳的治疗效果。世界卫生组织的数据显示,2020年全球败血症病例达4,890万例,死亡人数达1,100万,约占所有记录死亡人数的20%。便携式和穿戴式血液净化设备的推出增强了患者的活动能力,尤其对于需要频繁治疗的患者而言。这些不断发展的解决方案正在超越传统的透析,能够同时治疗急性和慢性疾病,并为医疗保健提供者和设备製造商创造更广泛的机会。
重症监护治疗需求不断成长
需要重症监护的患者数量不断增加,尤其是在 ICU 中,这推动了血液净化设备市场的扩张。最近的研究表明,全球对重症监护服务的需求激增了 30-40%,这主要是由于人口老化,在已开发国家,65 岁及以上的人占 ICU 入院人数的近 60%。败血症、器官衰竭和严重发炎等危及生命的疾病通常需要血液净化程序来消除有害物质并稳定患者病情。 COVID-19 危机进一步凸显了这些装置在治疗严重併发症的重要性。人们越来越认识到体外血液净化在重症监护中的有效性,加上公共医疗保健投资旨在透过先进的净化系统升级 ICU 的能力,在加速市场成长方面发挥重要作用。
The global blood purification equipment market size was valued at USD 22.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 36.7 Billion by 2033, exhibiting a CAGR of 5.76% during 2025-2033. Asia-Pacific currently dominates the market. The rising incidence of kidney-related ailments, the growing demand for intensive care services, and continuous innovations in medical technologies are significantly contributing to the expansion of this industry. These factors are collectively driving the growth and positively influencing the global blood purification equipment market share.
The market for blood purification equipment is seeing a steady shift toward compact and portable devices. This is mainly due to the growing focus on home-based treatments and the need for flexible care options for patients with chronic illnesses. Portable units offer ease of use, quicker setup, and increased comfort for users, which is especially helpful for elderly patients or those requiring regular dialysis. These devices are becoming more advanced, with features that allow for efficient filtration without compromising on performance. Healthcare providers are also supporting this shift as portable models reduce patient load in hospitals and clinics. A notable development in 2024 was the launch of lightweight models with real-time monitoring features, enhancing safety during use at home. Manufacturers are also focusing on battery life improvements and user-friendly interfaces. The availability of remote support through connected apps is helping users manage treatment with minimal supervision.
The United States stands out as a key market disruptor, driven by the rapid adoption of cutting-edge technologies in blood purification systems and a strong focus on patient-centered care. Healthcare providers in the US are prioritizing efficiency, accuracy, and reduced treatment times, which has encouraged manufacturers to invest in smarter equipment with real-time monitoring and automated controls. The integration of AI-powered diagnostics, improved membrane technologies, and user-friendly interfaces is becoming more common across hospitals and outpatient dialysis centers. In 2024, multiple US-based firms introduced AI-assisted devices that automatically adapt purification cycles based on patient vitals, enhancing treatment precision and safety. There has also been a marked shift toward connectivity, with cloud-based data tracking now being used to manage patient records and device performance remotely. These innovations help clinicians make faster decisions while also supporting remote patient management an important feature as telehealth expands across the country.
Increasing Prevalence of Kidney Diseases
The surge in demand for blood purification equipment is primarily driven by the growing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). NCBI reports that CKD incidence and prevalence have risen by approximately 40% globally over the last thirty years. As impaired kidneys are unable to eliminate toxins effectively, more patients now rely on dialysis and similar blood-cleansing methods. Factors such as rising CKD cases, global health trends, increasing adoption of hemodialysis and hemofiltration systems, and a growing elderly population who are more vulnerable to kidney-related conditions are boosting market expansion. In response, manufacturers are consistently enhancing device safety, comfort, and efficiency for patient care. The healthcare infrastructure both in the developed and developing countries is expanding the dialysis infrastructure, thereby bringing this type of blood purification technology to a wider population base, that creates a positive blood purification equipment market outlook.
Technological Advancements in Blood Purification
An additional prime factor catalyzing the blood purification equipment market growth is the development of blood purification technologies at a higher level of advancement. Advancements in filtration and adsorption technologies have significantly improved the removal of toxins, immune complexes, and metabolic waste from the bloodstream. Modern systems like high-flux dialyzers and next-generation hemoperfusion cartridges offer enhanced treatment outcomes for patients with sepsis, autoimmune disorders, and multiple organ dysfunctions. As per the World Health Organization, sepsis contributed to 48.9 Million cases and 11 Million deaths globally in 2020-around 20% of all recorded deaths. The introduction of portable and wearable blood purification devices is enhancing patient mobility, especially for those requiring frequent sessions. These evolving solutions are expanding beyond traditional dialysis, enabling treatment for both acute and chronic conditions and creating broader opportunities for healthcare providers and device manufacturers.
Increasing Demand for Critical Care Treatment
The rising number of patients in need of intensive care, especially in ICUs, is fueling the expansion of the blood purification equipment market. Recent studies show that global demand for critical care services has surged by 30-40%, largely due to the aging population, with individuals aged 65 and older making up nearly 60% of ICU admissions in developed nations. Life-threatening conditions such as sepsis, organ failure, and severe inflammation often require blood purification procedures to eliminate harmful agents and stabilize patients. The COVID-19 crisis further underscored the importance of these devices in managing serious complications. Increased recognition of extracorporeal blood purification's effectiveness in critical care, along with public healthcare investments aimed at upgrading ICU capabilities with advanced purification systems, is playing a major role in accelerating market growth.
In 2024, the portable segment led the blood purification equipment market, driven by growing demand for home-based and point-of-care treatments among patients with chronic illnesses. The convenience of compact, user-friendly machines enabled wider use beyond hospital settings, particularly for elderly and mobility-restricted individuals. Increasing awareness of personal health management, coupled with advancements in device miniaturization and battery efficiency, encouraged adoption. Telehealth integration further enhanced remote monitoring capabilities. As healthcare systems globally emphasized decentralized care delivery, portable equipment gained preference over bulky, stationary counterparts. Rising prevalence of kidney disorders and sepsis also supported demand for portable blood purification devices in both urban and rural regions.
In 2024, the renal diseases segment led the blood purification equipment market, driven by the rising global burden of chronic kidney disease (CKD), diabetes, and hypertension-related complications. An increasing number of patients progressed to end-stage renal disease (ESRD), requiring long-term blood purification therapies such as hemodialysis and hemofiltration. Early diagnosis efforts and public screening programs expanded patient intake into treatment cycles. The need for effective toxin removal and fluid balance in renal patients heightened demand for advanced purification systems. Additionally, updated clinical guidelines and wider insurance coverage encouraged continuous therapy adoption. The renal disease segment thus became a consistent and high-volume demand source for such equipment.
In 2024, the dialysis centers segment led the blood purification equipment market, driven by increasing investments in infrastructure, rising patient dependency on outpatient dialysis services, and the centralized management of chronic kidney treatments. Dialysis centers offered scalable care models with cost efficiencies, trained staff, and standardized protocols, making them ideal locations for regular blood purification procedures. Governments and private providers focused on expanding dialysis access, especially in semi-urban areas, supporting the installation of advanced equipment. Higher patient throughput in these centers compared to homecare settings encouraged bulk procurement and long-term service agreements. The growing prevalence of CKD further ensured steady demand across regional dialysis networks.
In 2024, the Asia-Pacific region dominated the blood purification equipment market, supported by fast-paced urban development, a rising burden of chronic kidney and metabolic disorders, and expanding healthcare infrastructure. Countries such as China and India experienced higher dialysis demand due to the growing number of CKD cases and limited access to organ transplants. Government programs enhanced dialysis accessibility, promoted domestic manufacturing, and encouraged collaboration between public and private sectors. Increased health awareness, better diagnostics, and broader insurance coverage played a role in early detection and consistent treatment uptake. Additionally, the region's competitive manufacturing capabilities and growing exports of affordable medical devices reinforced its strong position. Furthermore, these factors significantly influence the blood purification equipment market statistics, thereby highlighting Asia-Pacific's role as a leading growth contributor globally.
United States Blood Purification Equipment Market Analysis
The US market is witnessing strong growth owing to a surge in metabolic disorders, particularly chronic kidney disease (CKD) and end-stage renal failure. These conditions are driving the demand for renal replacement therapies. Nearly 815,000 Americans live with kidney failure, with about 555,000 relying on dialysis treatment. The American Kidney Fund indicates that over 14% of U.S. adults are affected by kidney disease. The rising number of critical care admissions linked to infectious and cardiovascular complications is also contributing to higher demand for blood purification solutions. The adoption of AI and IoT in healthcare devices is enhancing functionality through real-time monitoring and operational optimization. Additionally, modernization of hospital infrastructure and favorable reimbursement frameworks are supporting the uptake of advanced purification systems. Increased investment in biomedical research further strengthens the market outlook.
Europe Blood Purification Equipment Market Analysis
Europe's market growth is being fueled by a rise in chronic illnesses, particularly among aging populations in countries such as Germany and Italy. According to Germany's "9th Aging Report," the population aged 80+ could reach up to 10 Million by 2050. This demographic shift is escalating the need for treatments like blood purification. Patient inclination toward less invasive procedures has led to wider adoption of innovative technologies, including devices with improved biocompatibility and nanomaterials. Enhanced efficiency and durability of these systems are gaining traction. The region is also witnessing increasing investment in healthcare facilities and rising cases of sepsis, demanding swift therapeutic interventions. Regulatory support and heightened awareness about early intervention techniques are further contributing to market development.
Asia Pacific Blood Purification Equipment Market Analysis
The Asia Pacific region is experiencing rapid market expansion, underpinned by ongoing urban development and improved access to quality healthcare services. Rising incidences of acute kidney injuries and liver-related complications in major countries like China and India are creating substantial demand for purification equipment. Government initiatives are increasing healthcare funding and broadening access to modern treatments. New dialysis centers in rural and peri-urban areas are improving treatment availability for wider populations. Additionally, the region's growing medical tourism sector, especially in Thailand and Malaysia, is boosting the market. Thailand alone catered to approximately three Million international patients in 2024. In 2019, the country's medical tourism industry generated around USD 9 Billion in foreign exchange, further emphasizing the sector's economic impact.
Latin America Blood Purification Equipment Market Analysis
Latin America's market is expanding due to a rise in CKD and renal failure cases, necessitating advanced blood purification therapies. Healthcare infrastructure improvements in countries like Brazil and Mexico are improving service accessibility. Brazil's government, for instance, announced over BRL 58 Billion in healthcare investment plans through 2026, including BRL 9.9 Billion earmarked for Ceis under PAC and BNDES funding. Rising public awareness around kidney health and increased international collaborations are accelerating the adoption of sophisticated purification technologies. These efforts are making treatments more accessible across both metropolitan and remote regions, contributing to the overall market momentum.
Middle East and Africa Blood Purification Equipment Market Analysis
This regional market is growing due to escalating healthcare investments and a rise in kidney-related illnesses. Data from NCBI estimates that CKD prevalence in sub-Saharan Africa ranges from 2% to 41%, with South Africa alone reporting rates between 5.9% and 28.9%. Expansion of healthcare services, especially in underserved areas, is improving patient access to purification equipment. Government-led reforms and support for medical research are accelerating the deployment of innovative technologies. With rising healthcare standards and increased policy focus on non-communicable disease management, the demand for blood purification systems continues to grow across the region.
Ongoing advancements in medical device technology, treatment delivery methods, and patient engagement strategies are driving growth in the blood purification equipment market. Companies in the sector are prioritizing improvements in device accuracy, portability, and treatment efficiency to enhance clinical outcomes and user convenience. Firms compete by offering reliable, high-performance purification systems, remote monitoring capabilities, and customizable features tailored to different patient needs and care settings. Strategic collaborations, international market expansion, and targeted product development are supporting broader adoption. According to blood purification equipment market forecasts, demand is set to increase as healthcare systems focus on chronic disease management, decentralized care, and technology-enabled treatment solutions, encouraging greater investment in innovation, infrastructure, and patient-centric designs.